Level 4 - Ongoing CRO Oversight and Strategic Trial Governance

At this stage, biotech teams often ask:

• Am I receiving monthly updates but still lacking true strategic visibility?

• Do I see change orders appearing without fully understanding the long-term pattern?

• Am I confident that our oversight over the CRO matches what we contractually expected?

• Is our budget burn under control — or just appearing stable on the surface?

• As we approach key milestones, do I have a clear view of execution risk and timeline pressure?

• Are we drifting from our original protocol intent without explicitly acknowledging it?

• Am I reacting to events as they happen rather than anticipating inflection points?

Is this stage familiar?

Vendor Oversight & Governance Control

• Oversight visibility vs contractual expectations

• Effectiveness of escalation and issue resolution

• Sponsor vs CRO decision clarity

Clinical & Protocol Alignment

• Operational impact of protocol deviations

• Operational drift from development strategy

• Alignment with original regulatory positioning

Financial Performance & Risk Exposure

• Budget performance vs baseline

• Change order trend analysis

• Payment vs milestone alignment

• Capital exposure under execution variability

Milestone & Execution Risk Anticipation

• Upcoming inflection points

• Enrollment velocity sustainability

• Timeline pressure signals

• Cross-functional dependency risks

Strategic Drift Detection

• Early misalignment signals

• Incentive distortion risks

• Execution-model sustainability

• Long-term impact of short-term adjustments

Executive-level oversight across five dimensions:

What We Oversee

What You Receive

Strategic Trial Oversight Brief

Executive-level synthesis of financial performance, governance quality, operational risk signals, and strategic drift indicators.

Change Order & Budget Exposure Dashboard

Clear visibility of financial evolution and exposure patterns.

Milestone Risk & Inflection Report

Forward-looking risk anticipation around critical execution phases.

Independent Strategic Decision Briefings

Structured, neutral advisory input before major operational or financial decisions.

Level 4 ensures your trial remains strategically governed, and not just operationally managed.

Engagement scope and investment vary depending on trial complexity and stage. All collaborations begin with a structured exploratory discussion.